Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Sell
53,510
-200
-0.4% -$42.9K 0.02% 437
2026
Q1
$11.9M Sell
53,710
-1,700
-3% -$416K 0.03% 399
2025
Q4
$14M Sell
55,410
-22,251
-29% -$5.59M 0.03% 372
2025
Q3
$19.2M Buy
77,661
+215
+0.3% +$51.5K 0.05% 306
2025
Q2
$18.6M Buy
77,446
+29,863
+63% +$6.95M 0.05% 306
2025
Q1
$10.8M Sell
47,583
-4,843
-9% -$1.07M 0.03% 394
2024
Q4
$10.8M Buy
52,426
+9,243
+21% +$2.03M 0.03% 396
2024
Q3
$10.5M Buy
43,183
+2,300
+6% +$538K 0.03% 384
2024
Q2
$8.98M Sell
40,883
-37,661
-48% -$8.18M 0.03% 395
2024
Q1
$17.7M Buy
+78,544
New +$17.7M 0.06% 297

Other funds holding STE

Danske Bank's STE Position: Q2 2026 in Review

Danske Bank reduced its Steris (STE) stake by 0.37% in Q2 2026, selling an estimated $42.9K and leaving 53,510 shares worth $11.3M. The position accounts for 0.02% of the portfolio, ranked #437.

Danske Bank first reported a position in STE in Q1 2024 and has held it in 10 quarters since. The position peaked at $19.2M in Q3 2025. 722 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Danske Bank held 53,510 shares of Steris worth $11.3M as of Q2 2026.
  • Danske Bank sold 200 Steris shares in Q2 2026, an estimated $42.9K.
  • Steris made up 0.02% of Danske Bank's portfolio in Q2 2026, its #437 holding.
  • Danske Bank first reported a position in Steris in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Steris position peaked at $19.2M in Q3 2025.
  • 722 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.